However, the treatments containing 1.5% PHCs contamination with the presence of BC1 and BC2, a substantial decrease of 16.9% and 23.6% in proline, 21.9% and 24.0% CAT, 18.9% and 23.7% in SOD and 17.8% and 22.7% in POD contents, respectively was observed in comparison to uninoculated control (with 1.5% PHCs but without BC) (Table 4). This evidence concerns the gene CAT and breast cancer.